CEO of controversial drug company Insys is out
November 05, 2015 at 08:29 AM EST
Michael Babich, CEO of Insys Therapeutics, which is subject to several state and federal inquiries about its painkiller Subsys, has been replaced.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.